These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10192503)

  • 41. Major histocompatibility complex class II alleles in Kawasaki syndrome--lack of consistent correlation with disease or cardiac involvement.
    Barron KS; Silverman ED; Gonzales JC; St Clair M; Anderson K; Reveille JD
    J Rheumatol; 1992 Nov; 19(11):1790-3. PubMed ID: 1491403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis.
    Carter MJ; Jones S; Camp NJ; Cox A; Mee J; Warren B; Duff GW; Lobo AJ; di Giovine FS
    Genes Immun; 2004 Jan; 5(1):8-15. PubMed ID: 14735144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration.
    Kalsi JK; Grossman J; Kim J; Sieling P; Gjertson DW; Reed EF; Ebling FM; Linker-Israeli M; Hahn BH
    Lupus; 2004; 13(7):490-500. PubMed ID: 15352419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions.
    Barcellos LF; May SL; Ramsay PP; Quach HL; Lane JA; Nititham J; Noble JA; Taylor KE; Quach DL; Chung SA; Kelly JA; Moser KL; Behrens TW; Seldin MF; Thomson G; Harley JB; Gaffney PM; Criswell LA
    PLoS Genet; 2009 Oct; 5(10):e1000696. PubMed ID: 19851445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.
    Vamvakopoulos J; Green C; Metcalfe S
    Eur J Immunol; 2002 Oct; 32(10):2988-96. PubMed ID: 12355453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes--evidence for polygenicity in man. Danish Study Group of Diabetes in Childhood.
    Pociot F; Rønningen KS; Bergholdt R; Lorenzen T; Johannesen J; Ye K; Dinarello CA; Nerup J
    Autoimmunity; 1994; 19(3):169-78. PubMed ID: 7605869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
    Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of HLA-DQB1 allelic sequence variation with susceptibility to systemic lupus erythematosus.
    Rezaieyazdi Z; Tavakkol-Afshari J; Esmaili E; Orouji E; Pezeshkpour F; Khodadoost M; Mazhani M; Sandooghi M
    Iran J Allergy Asthma Immunol; 2008 Jun; 7(2):91-5. PubMed ID: 18552411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preliminary report on class II histocompatibility (HLA-DR and DQ) antigens in a subpopulation of Arab patients with systemic lupus erythematosus.
    Al Attia HM; Mahmud N
    Int J Rheum Dis; 2011 Aug; 14(3):e44-6. PubMed ID: 21816014
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction.
    Tazi-Ahnini R; Cox A; McDonagh AJ; Nicklin MJ; di Giovine FS; Timms JM; Messenger AG; Dimitropoulou P; Duff GW; Cork MJ
    Eur J Immunogenet; 2002 Feb; 29(1):25-30. PubMed ID: 11841485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphisms of the TAP2 transporter gene in systemic lupus erythematosus.
    Davies EJ; Donn RP; Hillarby MC; Grennan DM; Ollier WE
    Ann Rheum Dis; 1994 Jan; 53(1):61-3. PubMed ID: 8311559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome?
    Freitas MV; da Silva LM; Deghaide NH; Donadi EA; Louzada-Júnior P
    Lupus; 2004; 13(2):125-31. PubMed ID: 14995006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitivity to bee venom antigen phospholipase A2: association with specific HLA class I and class II alleles and haplotypes in beekeepers and allergic patients.
    Sánchez-Velasco P; Antón E; Muñoz D; Martínez-Quesada J; Ruíz de Alegría C; López-Hoyos M; García-Martín A; Jiménez I; Alonso ST; Duque S; Suárez A; Jerez J; Leyva-Cobián F
    Hum Immunol; 2005 Jul; 66(7):818-25. PubMed ID: 16112029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes.
    Hurme M; Santtila S
    Eur J Immunol; 1998 Aug; 28(8):2598-602. PubMed ID: 9710237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10.
    D'Alfonso S; Rampi M; Bocchio D; Colombo G; Scorza-Smeraldi R; Momigliano-Richardi P
    Arthritis Rheum; 2000 Jan; 43(1):120-8. PubMed ID: 10643707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus.
    Blakemore AI; Tarlow JK; Cork MJ; Gordon C; Emery P; Duff GW
    Arthritis Rheum; 1994 Sep; 37(9):1380-5. PubMed ID: 7945503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy.
    Watanabe M; Iwano M; Akai Y; Kurioka H; Nishitani Y; Harada K; Hamano K; Shiiki H
    Nephron; 2002 Aug; 91(4):744-6. PubMed ID: 12138282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis.
    Perrier S; Coussediere C; Dubost JJ; Albuisson E; Sauvezie B
    Clin Immunol Immunopathol; 1998 Jun; 87(3):309-13. PubMed ID: 9646842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus.
    Goldstein R; Sengar DP
    Arthritis Rheum; 1993 Aug; 36(8):1121-7. PubMed ID: 8343187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis.
    Vencovský J; Jarosová K; Růzicková S; Nemcová D; Niederlová J; Ozen S; Alikasifoglu M; Bakkaloglu A; Ollier WE; Mageed RA
    Arthritis Rheum; 2001 Oct; 44(10):2387-91. PubMed ID: 11665981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.